CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 24 filers reported holding CANDEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,313 | -26.2% | 132,595 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $167,070 | -8.1% | 132,595 | -0.1% | 0.00% | -20.0% |
| Q1 2023 | $181,799 | -23.5% | 132,700 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $237,533 | -43.0% | 132,700 | 0.0% | 0.01% | -45.5% |
| Q3 2022 | $417,000 | -3.0% | 132,700 | 0.0% | 0.01% | +10.0% |
| Q2 2022 | $430,000 | +12.6% | 132,700 | +76.9% | 0.01% | +42.9% |
| Q1 2022 | $382,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $1,780,398 | 5.13% |
| Sands Capital Ventures, LLC | 811,737 | $746,798 | 0.22% |
| Empirical Asset Management, LLC | 10,000 | $9,200 | 0.01% |
| Baystate Wealth Management LLC | 97,310 | $89,525 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,595 | $123,313 | 0.00% |
| FRANKLIN RESOURCES INC | 1,125,000 | $1,046,250 | 0.00% |
| OneDigital Investment Advisors LLC | 25,428 | $23,394 | 0.00% |
| WELLS FARGO & COMPANY/MN | 108 | $99 | 0.00% |
| NORTHERN TRUST CORP | 19,617 | $18,048 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |